Magnus Nicholson – Invizius CEO
Invizius, an Edinburgh-based biotech company pioneering treatments for dialysis patients, has secured £950,000 in funding. The funding round was led by Mercia Ventures and supported by Calculus Capital, Syensqo, the University of Edinburgh’s Old College Capital, and Scottish Enterprise. The latest investment will…
Read More…